Calithera Biosciences, Inc.
Calithera Biosciences, Inc. (CALA) Revenue
Annual & quarterly revenue history · segment & region breakdown
CALA · revenue · updated Jun 8, 2026
Core revenue metrics
Trailing 12 monthsCalithera Biosciences, Inc. trailing twelve-month (TTM) revenue is $0.00B, a decrease of 100.00% year-over-year from $0.00B in FY2022.
Revenue trend
2022 – 2012 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2022-12-31 | $0.00B | -$0.01B | -100.00% |
| 2021-12-31 | $0.01B | +$0.01B | — |
| 2020-12-31 | $0.00B | +$0.00B | — |
| 2019-12-31 | $0.00B | -$0.02B | -100.00% |
| 2018-12-31 | $0.02B | -$0.00B | -14.26% |
| 2017-12-31 | $0.03B | +$0.03B | — |
| 2016-12-31 | $0.00B | +$0.00B | — |
| 2015-12-31 | $0.00B | +$0.00B | — |
| 2014-12-31 | $0.00B | +$0.00B | — |
| 2013-12-31 | $0.00B | +$0.00B | — |
Revenue breakdown
Segment & GeographyAbout Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Calithera Biosciences, Inc. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Calithera Biosciences, Inc. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from Calithera Biosciences, Inc.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
CALA revenue · 4 questionsCALA's trailing twelve-month (TTM) revenue is $0.00B. That is a decrease of 100.00% year-over-year from $0.00B in FY2022.
▸ Source: FMP · Calithera Biosciences, Inc. SEC filings · GAAP · Calithera Biosciences, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026